Sign in
Groups
Researchers
Results
HOSPITAL UNIVERSITARIO RUBER
Department
First Hospital of Jilin University
Changchun, China
You are in
Collaborations
First Hospital of Jilin University
Publications in collaboration with researchers from First Hospital of Jilin University (2)
2023
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
The Lancet, Vol. 401, Núm. 10371, pp. 105-117
2016
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 17, Núm. 3, pp. 357-366
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de